Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

173.15
+0.09000.05%
Post-market: 173.150.00000.00%17:49 EDT
Volume:484.69K
Turnover:84.32M
Market Cap:10.45B
PE:-27.51
High:177.06
Open:175.85
Low:172.00
Close:173.06
Loading ...

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
19 Feb

Ascendis Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
18 Feb

Ascendis Pharma A/S (NASDAQ:ASND) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St.
·
15 Feb

Ascendis Pharma Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
14 Feb

Evercore ISI Remains a Buy on Ascendis Pharma (ASND)

TIPRANKS
·
14 Feb

Ascendis Pharma AS (ASND) Q4 2024 Earnings Call Highlights: Strategic Growth and Market ...

GuruFocus.com
·
14 Feb

Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges

TIPRANKS
·
14 Feb

Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?

Benzinga
·
14 Feb

European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT Newswires Live
·
14 Feb

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
14 Feb

Stock Track | Ascendis Pharma Soars Over 11% on Upbeat Q4 Results, Share Buyback Plan

Stock Track
·
13 Feb

Stock Track | Ascendis Pharma Soars Over 8% Pre-Market on Strong Q4 Earnings, Buyback Plan

Stock Track
·
13 Feb

Ascendis Pharma (ASND) Receives a Buy from J.P. Morgan

TIPRANKS
·
13 Feb

Ascendis Pharma price target lowered to $192 from $203 at BofA

TIPRANKS
·
13 Feb

Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs

MT Newswires Live
·
13 Feb

Ascendis Pharma a/S : Jefferies Raises Target Price to $223 From $194

THOMSON REUTERS
·
13 Feb

Ascendis Pharma A/S Reports Strong 2024 Financial Growth

TIPRANKS
·
13 Feb

Ascendis Pharma A/S reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement Of Certain Rsus

Reuters
·
13 Feb

Stock Track | Ascendis Pharma Soars 6% After Hours on Q4 Beat, Buyback Plan

Stock Track
·
13 Feb